CSL to Support new
Biopharmaceutical Training Centre at UQ
University of Queensland

4-July-2016 — CSL will be an inaugural partner of the new Australian Research Council Industrial Transformation Training Centre for Biopharmaceutical Innovation to be established at the University of Queensland. More.

CSL Behring is 2016
‘Victorian Manufacturer of the Year’ CSL Behring operates two plasma product manufacturing facilities and a Biotechnology Manufacturing Facility at its 24 ha site in Broadmeadows Victoria

10-June-2016 — Last night CSL Behring’s Australian facility was awarded ‘2016 Victorian Manufacturer of the Year’ at the Victorian Manufacturing Hall of Fame Awards. More.


Other recent news:

06-June-2016 — Seqirus donates vaccines to Fiji to alleviate increase in influenza. More.
01-June-2016 — Call for applications for CSL Centenary Fellowships. Two five-year fellowships awarded each calendar year, for ten years. More.
26-May-2016 — The US Food and Drug Administration (FDA) has approved CSL Behring's AFSTYLA® [Antihaemophilic Factor (Recombinant), Single Chain]. More.

© 2016 CSL Limited